Hepatitis C Virus Positivity Should Not Be Included in the Kidney Donor Profile Index Calculation When Transplanting HCV-Positive Kidneys Into Noninfected Recipients in the Era of Direct-Acting Antiviral Agents

Prog Transplant. 2019 Dec;29(4):371-372. doi: 10.1177/1526924819874373. Epub 2019 Sep 18.
No abstract available

Keywords: HCV; KDPI; deceased donor kidney transplant; kidney clinical; kidney outcomes.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antiviral Agents / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Donor Selection*
  • Drug Combinations
  • Hepacivirus
  • Hepatitis C, Chronic / drug therapy*
  • Hepatitis C, Chronic / transmission
  • Humans
  • Kidney Transplantation*
  • Patient Selection
  • Postoperative Complications / drug therapy*
  • Pyrrolidines / therapeutic use*
  • Quinoxalines / therapeutic use*
  • Sulfonamides / therapeutic use*
  • Transplants / virology*

Substances

  • Antiviral Agents
  • Benzimidazoles
  • Drug Combinations
  • Pyrrolidines
  • Quinoxalines
  • Sulfonamides
  • glecaprevir and pibrentasvir